{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:58:05Z","timestamp":1792166285851,"version":"4.4.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:00:00Z","timestamp":1765584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100014717","name":"National Outstanding Youth Science Fund Project of National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403716"],"award-info":[{"award-number":["82403716"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Jiangxi Natural Science Foundation","doi-asserted-by":"crossref","award":["20232BAB216073"],"award-info":[{"award-number":["20232BAB216073"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Key Projects of Jiangxi Administration of Traditional Chinese Medicine","award":["GZY-KJS-2023-028"],"award-info":[{"award-number":["GZY-KJS-2023-028"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Precis. Onc."],"DOI":"10.1038\/s41698-025-01185-0","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T08:46:08Z","timestamp":1765615568000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Exosomal SNHG26 mediates immunosuppression by impairing NK cells in tongue cancer"],"prefix":"10.1038","volume":"9","author":[{"given":"Qingkun","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqin","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenshu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxuan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,13]]},"reference":[{"key":"1185_CR1","first-page":"7","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel, R. L., Miller, K. D., Fuchs, H. E. & Jemal, A. Cancer statistics, 2022. CA Cancer J. Clin. 72, 7\u201333 (2022).","journal-title":"CA Cancer J. Clin."},{"key":"1185_CR2","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"1185_CR3","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/odi.14450","volume":"30","author":"L Xie","year":"2022","unstructured":"Xie, L. & Shang, Z. Changing trend of oral cancer disease burden in china from 1990 to 2019 and the forecast for the next 20 years. Oral. Dis. 30, 195\u2013206 (2022).","journal-title":"Oral. Dis."},{"key":"1185_CR4","first-page":"D10173","volume":"12","author":"T Walsh","year":"2021","unstructured":"Walsh, T. et al. Clinical assessment for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults. Cochrane Database Syst. Rev. 12, D10173 (2021).","journal-title":"Cochrane Database Syst. Rev."},{"key":"1185_CR5","doi-asserted-by":"publisher","first-page":"224","DOI":"10.6004\/jnccn.2022.0016","volume":"20","author":"JJ Caudell","year":"2022","unstructured":"Caudell, J. J. et al. Nccn guidelines(r) insights: head and neck cancers, version 1.2022. J. Natl Compr. Cancer Netw. 20, 224\u2013234 (2022).","journal-title":"J. Natl Compr. Cancer Netw."},{"key":"1185_CR6","doi-asserted-by":"publisher","first-page":"105122","DOI":"10.1016\/j.oraloncology.2020.105122","volume":"113","author":"N Subramaniam","year":"2021","unstructured":"Subramaniam, N. et al. Geographical heterogeneity in the American joint committee on cancer oral cancer staging and prognostic implications. Oral. Oncol. 113, 105122 (2021).","journal-title":"Oral. Oncol."},{"key":"1185_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-021-01119-6","volume":"23","author":"TB de Oliveira","year":"2021","unstructured":"de Oliveira, T. B., Marta, G. N., de Castro, J. G. & Kowalski, L. P. Induction chemotherapy for advanced oral cavity cancer. Curr. Oncol. Rep. 23, 129 (2021).","journal-title":"Curr. Oncol. Rep."},{"key":"1185_CR8","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1200\/JCO.2012.43.8820","volume":"31","author":"LP Zhong","year":"2013","unstructured":"Zhong, L. P. et al. Randomized phase iii trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma. J. Clin. Oncol. 31, 744\u2013751 (2013).","journal-title":"J. Clin. Oncol."},{"key":"1185_CR9","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.cell.2020.05.007","volume":"181","author":"F Klemm","year":"2020","unstructured":"Klemm, F. et al. Interrogation of the microenvironmental landscape in brain tumors reveals disease-specific alterations of immune cells. Cell 181, 1643\u20131660 (2020).","journal-title":"Cell"},{"key":"1185_CR10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12929-022-00866-3","volume":"29","author":"A Tiwari","year":"2022","unstructured":"Tiwari, A., Trivedi, R. & Lin, S. Y. Tumor microenvironment: barrier or opportunity towards effective cancer therapy. J. Biomed. Sci. 29, 83 (2022).","journal-title":"J. Biomed. Sci."},{"key":"1185_CR11","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1158\/1078-0432.CCR-20-0197","volume":"27","author":"C Watermann","year":"2021","unstructured":"Watermann, C. et al. Recurrent hnscc harbor an immunosuppressive tumor immune microenvironment suggesting successful tumor immune evasion. Clin. Cancer Res. 27, 632\u2013644 (2021).","journal-title":"Clin. Cancer Res."},{"key":"1185_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01737-7","volume":"22","author":"Y Zhou","year":"2023","unstructured":"Zhou, Y., Cheng, L., Liu, L. & Li, X. Nk cells are never alone: crosstalk and communication in tumour microenvironments. Mol. Cancer 22, 34 (2023).","journal-title":"Mol. Cancer"},{"key":"1185_CR13","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1038\/s41591-022-02003-x","volume":"28","author":"Y Li","year":"2022","unstructured":"Li, Y. et al. Kir-based inhibitory cars overcome car-nk cell trogocytosis-mediated fratricide and tumor escape. Nat. Med. 28, 2133\u20132144 (2022).","journal-title":"Nat. Med."},{"key":"1185_CR14","doi-asserted-by":"publisher","first-page":"17802","DOI":"10.1021\/acsnano.2c08774","volume":"16","author":"R Tenchov","year":"2022","unstructured":"Tenchov, R. et al. Exosomes horizontal line nature\u2019s lipid nanoparticles, a rising star in drug delivery and diagnostics. Acs Nano 16, 17802\u201317846 (2022).","journal-title":"Acs Nano"},{"key":"1185_CR15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1146\/annurev-pathmechdis-031521-022116","volume":"18","author":"JW Clancy","year":"2023","unstructured":"Clancy, J. W. & D\u2019Souza-Schorey, C. Tumor-derived extracellular vesicles: multifunctional entities in the tumor microenvironment. Annu. Rev. Pathol. Mech. Dis. 18, 205\u2013229 (2023).","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"1185_CR16","doi-asserted-by":"publisher","first-page":"106678","DOI":"10.1016\/j.phrs.2023.106678","volume":"188","author":"Z Yang","year":"2023","unstructured":"Yang, Z., Ma, R., Li, J. & Zhao, L. Noncoding rnas in esophageal cancer: a glimpse into implications for therapy resistance. Pharmacol. Res. 188, 106678 (2023).","journal-title":"Pharmacol. Res."},{"key":"1185_CR17","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.tcb.2022.01.006","volume":"32","author":"S Adnane","year":"2022","unstructured":"Adnane, S., Marino, A. & Leucci, E. LncRNAs in human cancers: signal from noise. Trends Cell Biol. 32, 565\u2013573 (2022).","journal-title":"Trends Cell Biol."},{"key":"1185_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2022.100915","volume":"67","author":"Z Yu","year":"2023","unstructured":"Yu, Z. et al. Exosomal loc85009 inhibits docetaxel resistance in lung adenocarcinoma through regulating atg5-induced autophagy. Drug Resist. Update 67, 100915 (2023).","journal-title":"Drug Resist. Update"},{"key":"1185_CR19","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1111\/febs.16668","volume":"291","author":"M Saeinasab","year":"2024","unstructured":"Saeinasab, M., Atlasi, Y. & M, M. M. Functional role of lncrnas in gastrointestinal malignancies: the peculiar case of small nucleolar rna host gene family. FEBS J. 291, 1353\u20131385 (2024).","journal-title":"FEBS J."},{"key":"1185_CR20","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.omto.2021.12.021","volume":"24","author":"Q Jiang","year":"2022","unstructured":"Jiang, Q. et al. LncRNA SNHG26 promoted the growth, metastasis, and cisplatin resistance of tongue squamous cell carcinoma through pgk1\/akt\/mtor signal pathway. Mol. Ther.-Oncolytics. 24, 355\u2013370 (2022).","journal-title":"Mol. Ther.-Oncolytics."},{"key":"1185_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01672-z","volume":"21","author":"L Tong","year":"2022","unstructured":"Tong, L. et al. Nk cells and solid tumors: therapeutic potential and persisting obstacles. Mol. Cancer 21, 206 (2022).","journal-title":"Mol. Cancer"},{"key":"1185_CR22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13046-022-02327-z","volume":"41","author":"K Pan","year":"2022","unstructured":"Pan, K. et al. CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy. J. Exp. Clin. Cancer Res. 41, 119 (2022).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"1185_CR23","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1056\/NEJMoa1910607","volume":"382","author":"E Liu","year":"2020","unstructured":"Liu, E. et al. Use of CAR-transduced natural killer cells in CD19-positive lymphoid tumors. N. Engl. J. Med. 382, 545\u2013553 (2020).","journal-title":"N. Engl. J. Med."},{"key":"1185_CR24","doi-asserted-by":"publisher","first-page":"e28147","DOI":"10.4161\/onci.28147","volume":"3","author":"H Klingemann","year":"2014","unstructured":"Klingemann, H. Are natural killer cells superior CAR drivers?. Oncoimmunology 3, e28147 (2014).","journal-title":"Oncoimmunology"},{"key":"1185_CR25","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.3389\/fimmu.2019.01179","volume":"10","author":"D Pende","year":"2019","unstructured":"Pende, D. et al. Killer Ig-like receptors (KIRs): their role in nk cell modulation and developments leading to their clinical exploitation. Front. Immunol. 10, 1179 (2019).","journal-title":"Front. Immunol."},{"key":"1185_CR26","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.3390\/cells9051141","volume":"9","author":"CPR Xavier","year":"2020","unstructured":"Xavier, C. P. R. et al. The role of extracellular vesicles in the hallmarks of cancer and drug resistance. Cells 9, 1141 (2020).","journal-title":"Cells"},{"key":"1185_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2020.188340","volume":"1873","author":"J Da\u00dfler-Plenker","year":"2020","unstructured":"Da\u00dfler-Plenker, J., K\u00fcttner, V. & Egeblad, M. Communication in tiny packages: exosomes as means of tumor-stroma communication. Biochim. Biophys. Acta Rev. Cancer 1873, 188340 (2020).","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"1185_CR28","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/JLB.3RU0420-668RR","volume":"109","author":"SA Erokhina","year":"2021","unstructured":"Erokhina, S. A. et al. HLA-DR-expressing nk cells: effective killers suspected for antigen presentation. J. Leukoc. Biol. 109, 327\u2013337 (2021).","journal-title":"J. Leukoc. Biol."},{"key":"1185_CR29","unstructured":"Whyte, C. E. et al. Context-dependent effects of IL-2 rewire immunity into distinct cellular circuits. J. Exp. Med. 219, e20212391 (2022)."},{"key":"1185_CR30","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s40259-022-00521-1","volume":"36","author":"NP Tschernia","year":"2022","unstructured":"Tschernia, N. P. & Gulley, J. L. Tumor in the crossfire: inhibiting TGF-\u03b2 to enhance cancer immunotherapy. Biodrugs 36, 153\u2013180 (2022).","journal-title":"Biodrugs"},{"key":"1185_CR31","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3389\/fimmu.2020.00311","volume":"11","author":"S Regis","year":"2020","unstructured":"Regis, S., Dondero, A., Caliendo, F., Bottino, C. & Castriconi, R. Nk cell function regulation by TGF-beta-induced epigenetic mechanisms. Front. Immunol. 11, 311 (2020).","journal-title":"Front. Immunol."},{"key":"1185_CR32","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/S1286-4579(99)00253-1","volume":"1","author":"DA Horwitz","year":"1999","unstructured":"Horwitz, D. A., Gray, J. D. & Ohtsuka, K. Role of nk cells and tgf-beta in the regulation of t-cell-dependent antibody production in health and autoimmune disease. Microbes Infect. 1, 1305\u20131311 (1999).","journal-title":"Microbes Infect."},{"key":"1185_CR33","doi-asserted-by":"publisher","first-page":"12173","DOI":"10.1002\/jcp.27955","volume":"234","author":"A Ahmadi","year":"2019","unstructured":"Ahmadi, A., Najafi, M., Farhood, B. & Mortezaee, K. Transforming growth factor-beta signaling: tumorigenesis and targeting for cancer therapy. J. Cell. Physiol. 234, 12173\u201312187 (2019).","journal-title":"J. Cell. Physiol."},{"key":"1185_CR34","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3389\/fonc.2020.00389","volume":"10","author":"AA Zimta","year":"2020","unstructured":"Zimta, A. A. et al. An emerging class of long non-coding RNA with oncogenic role arises from the snorna host genes. Front. Oncol. 10, 389 (2020).","journal-title":"Front. Oncol."},{"key":"1185_CR35","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202052124","volume":"22","author":"L Xin","year":"2021","unstructured":"Xin, L. et al. Transfer of lncRNA CRNDE in TAM-derived exosomes is linked with cisplatin resistance in gastric cancer. EMBO Rep. 22, e52124 (2021).","journal-title":"EMBO Rep."},{"key":"1185_CR36","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.semcancer.2019.08.007","volume":"67","author":"D Novak","year":"2020","unstructured":"Novak, D. et al. Sox2 in development and cancer biology. Semin. Cancer Biol. 67, 74\u201382 (2020).","journal-title":"Semin. Cancer Biol."},{"key":"1185_CR37","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s12253-018-0506-5","volume":"25","author":"R Zhang","year":"2019","unstructured":"Zhang, R., Zhang, J., Luo, W., Luo, Z. & Shi, S. Wwp2 is one promising novel oncogene. Pathol. Oncol. Res. 25, 443\u2013446 (2019).","journal-title":"Pathol. Oncol. Res."},{"key":"1185_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26653-6","volume":"12","author":"T Mahlokozera","year":"2021","unstructured":"Mahlokozera, T. et al. Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. Nat. Commun. 12, 6321 (2021).","journal-title":"Nat. Commun."},{"key":"1185_CR39","doi-asserted-by":"publisher","first-page":"12420","DOI":"10.1080\/21655979.2021.2005221","volume":"12","author":"J Yan","year":"2021","unstructured":"Yan, J. & Xu, H. Regulation of transforming growth factor-beta1 by circanks1b\/mir-515-5p affects the metastatic potential and cisplatin resistance in oral squamous cell carcinoma. Bioengineered 12, 12420\u201312430 (2021).","journal-title":"Bioengineered"},{"key":"1185_CR40","doi-asserted-by":"publisher","first-page":"5739","DOI":"10.7150\/thno.37556","volume":"9","author":"W Chen","year":"2019","unstructured":"Chen, W. et al. Decreased expression of mitochondrial miR-5787 contributes to chemoresistance by reprogramming glucose metabolism and inhibiting MT-CO3 translation. Theranostics 9, 5739\u20135754 (2019).","journal-title":"Theranostics"},{"key":"1185_CR41","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.cell.2017.11.010","volume":"172","author":"N Sachs","year":"2018","unstructured":"Sachs, N. et al. A living biobank of breast cancer organoids captures disease heterogeneity. Cell 172, 373\u2013386 (2018).","journal-title":"Cell"},{"key":"1185_CR42","doi-asserted-by":"publisher","first-page":"3135470","DOI":"10.1155\/2022\/3135470","volume":"2022","author":"F He","year":"2022","unstructured":"He, F. et al. Establishment and identification of patient-derived xenograft model for oral squamous cell carcinoma. J. Oncol. 2022, 3135470 (2022).","journal-title":"J. Oncol."},{"key":"1185_CR43","doi-asserted-by":"publisher","first-page":"12963","DOI":"10.1096\/fj.202001203R","volume":"34","author":"C Ye","year":"2020","unstructured":"Ye, C. et al. A rapid, sensitive, and reproducible in vivo pbmc humanized murine model for determining therapeutic-related cytokine release syndrome. FASEB J. 34, 12963\u201312975 (2020).","journal-title":"FASEB J."},{"key":"1185_CR44","doi-asserted-by":"publisher","first-page":"30829","DOI":"10.3402\/jev.v5.30829","volume":"5","author":"K Iwai","year":"2016","unstructured":"Iwai, K., Minamisawa, T., Suga, K., Yajima, Y. & Shiba, K. Isolation of human salivary extracellular vesicles by iodixanol density gradient ultracentrifugation and their characterizations. J. Extracell. Vesicles 5, 30829 (2016).","journal-title":"J. Extracell. Vesicles"},{"key":"1185_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01222-5","volume":"19","author":"PF Zhang","year":"2020","unstructured":"Zhang, P. F. et al. Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-pd1 therapy in hepatocellular carcinoma. Mol. Cancer 19, 110 (2020).","journal-title":"Mol. Cancer"}],"container-title":["npj Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-01185-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-01185-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-01185-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T12:02:30Z","timestamp":1766404950000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-01185-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,13]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1185"],"URL":"https:\/\/doi.org\/10.1038\/s41698-025-01185-0","relation":{},"ISSN":["2397-768X"],"issn-type":[{"value":"2397-768X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,13]]},"assertion":[{"value":"10 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"402"}}